Arcus Biosciences obtains $250m loan facility with Hercules Capital

The recent loan facility secured by Arcus Biosciences from Hercules Capital is strategically advantageous for both companies. Arcus Biosciences benefits significantly from this arrangement as it provides them with up to $200 million in funding, crucial for advancing their research and development initiatives, particularly in the costly and high-stakes biopharmaceutical industry. Importantly, this loan represents…

Read More

Not all bad news at Blackstone Mortgage Trust Inc. (BXMT) latest earnings call

Blackstone Mortgage Trust Inc. (BXMT) reported a GAAP net loss of $0.38 per share, but distributable earnings were $0.49 per share, indicating strong operational performance despite challenges. The company declared a third-quarter dividend of $0.47 per share and authorized a $150 million common stock repurchase, reflecting confidence in long-term value creation. BXMT has a 90% performing…

Read More